Cargando…

Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function

BACKGROUND: Reduced diastolic function is an early sign of diabetes cardiomyopathy in adults and is associated with elevated levels of HbA1c and advanced glycation end products (AGEs). OBJECTIVE: To assess the associations between early reduced diastolic function and elevated levels of HbA1c and AGE...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunvand, Leif, Heier, Martin, Brunborg, Cathrine, Hanssen, Kristian F., Fugelseth, Drude, Stensaeth, Knut Haakon, Dahl-Jørgensen, Knut, Margeirsdottir, Hanna Dis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445493/
https://www.ncbi.nlm.nih.gov/pubmed/28545398
http://dx.doi.org/10.1186/s12872-017-0551-0
_version_ 1783238904142364672
author Brunvand, Leif
Heier, Martin
Brunborg, Cathrine
Hanssen, Kristian F.
Fugelseth, Drude
Stensaeth, Knut Haakon
Dahl-Jørgensen, Knut
Margeirsdottir, Hanna Dis
author_facet Brunvand, Leif
Heier, Martin
Brunborg, Cathrine
Hanssen, Kristian F.
Fugelseth, Drude
Stensaeth, Knut Haakon
Dahl-Jørgensen, Knut
Margeirsdottir, Hanna Dis
author_sort Brunvand, Leif
collection PubMed
description BACKGROUND: Reduced diastolic function is an early sign of diabetes cardiomyopathy in adults and is associated with elevated levels of HbA1c and advanced glycation end products (AGEs). OBJECTIVE: To assess the associations between early reduced diastolic function and elevated levels of HbA1c and AGEs in children and adolescents with type 1 diabetes (T1D). METHODS: One hundred fourty six T1D patients (age 8–18 years) without known diabetic complications were examined with tissue Doppler imaging and stratified into two groups according to diastolic function. A clinical examination and ultrasound of the common carotid arteries were performed. Methylglyoxal-derived hydroimidazolone-1 (MG-H1) was measured by immunoassay. RESULTS: At inclusion, 36 (25%) participants were stratified into a low diastolic function group (E’/A’-ratio < 2.0). Compared to the rest of the T1D children, these participants had higher body mass index (BMI), 22.8 (SD = 4.0) vs. 20.1 (SD = 3.4) kg/m(2), p < 0.001, higher systolic blood pressure 104.2 (SD = 8.7) vs. 99.7 (SD = 9.3) mmHg, p = 0.010, and higher diastolic blood pressure, 63.6 (SD = 8.3) vs. 59.9 (SD = 7.9) mmHg, p = 0.016. The distensibility coefficient was lower, 0.035 (SD = 0.010) vs. 0.042 (SD = 0.02) kPa(−1), p = 0.013, Young’s modulus higher, 429 (SD = 106) vs. 365 (SD = 143), p = 0.009, and MG-H1 higher, 163.9 (SD = 39.2) vs. 150.3 (SD = 33.4) U/ml, p = 0.046. There was no difference in carotid intima-media thickness between the groups. There were no associations between reduced diastolic function and years from diagnosis, HBA1c, mean HBA1c, CRP or calculated glycemic burden. Logistic regression analysis showed that BMI was an independent risk factor for E’/A’-ratio as well as a non-significant, but relatively large effect size for MG-H1, indicating a possible role for AGEs. CONCLUSIONS: Early signs of reduced diastolic function in children and adolescents with T1D had higher BMI, but not higher HbA1c. They also had elevated serum levels of the advanced glycation end product MG-H1, higher blood pressure and increased stiffness of the common carotid artery, but these associations did not reach statistical significance when tested in a logistic regression model.
format Online
Article
Text
id pubmed-5445493
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54454932017-05-30 Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function Brunvand, Leif Heier, Martin Brunborg, Cathrine Hanssen, Kristian F. Fugelseth, Drude Stensaeth, Knut Haakon Dahl-Jørgensen, Knut Margeirsdottir, Hanna Dis BMC Cardiovasc Disord Research Article BACKGROUND: Reduced diastolic function is an early sign of diabetes cardiomyopathy in adults and is associated with elevated levels of HbA1c and advanced glycation end products (AGEs). OBJECTIVE: To assess the associations between early reduced diastolic function and elevated levels of HbA1c and AGEs in children and adolescents with type 1 diabetes (T1D). METHODS: One hundred fourty six T1D patients (age 8–18 years) without known diabetic complications were examined with tissue Doppler imaging and stratified into two groups according to diastolic function. A clinical examination and ultrasound of the common carotid arteries were performed. Methylglyoxal-derived hydroimidazolone-1 (MG-H1) was measured by immunoassay. RESULTS: At inclusion, 36 (25%) participants were stratified into a low diastolic function group (E’/A’-ratio < 2.0). Compared to the rest of the T1D children, these participants had higher body mass index (BMI), 22.8 (SD = 4.0) vs. 20.1 (SD = 3.4) kg/m(2), p < 0.001, higher systolic blood pressure 104.2 (SD = 8.7) vs. 99.7 (SD = 9.3) mmHg, p = 0.010, and higher diastolic blood pressure, 63.6 (SD = 8.3) vs. 59.9 (SD = 7.9) mmHg, p = 0.016. The distensibility coefficient was lower, 0.035 (SD = 0.010) vs. 0.042 (SD = 0.02) kPa(−1), p = 0.013, Young’s modulus higher, 429 (SD = 106) vs. 365 (SD = 143), p = 0.009, and MG-H1 higher, 163.9 (SD = 39.2) vs. 150.3 (SD = 33.4) U/ml, p = 0.046. There was no difference in carotid intima-media thickness between the groups. There were no associations between reduced diastolic function and years from diagnosis, HBA1c, mean HBA1c, CRP or calculated glycemic burden. Logistic regression analysis showed that BMI was an independent risk factor for E’/A’-ratio as well as a non-significant, but relatively large effect size for MG-H1, indicating a possible role for AGEs. CONCLUSIONS: Early signs of reduced diastolic function in children and adolescents with T1D had higher BMI, but not higher HbA1c. They also had elevated serum levels of the advanced glycation end product MG-H1, higher blood pressure and increased stiffness of the common carotid artery, but these associations did not reach statistical significance when tested in a logistic regression model. BioMed Central 2017-05-25 /pmc/articles/PMC5445493/ /pubmed/28545398 http://dx.doi.org/10.1186/s12872-017-0551-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Brunvand, Leif
Heier, Martin
Brunborg, Cathrine
Hanssen, Kristian F.
Fugelseth, Drude
Stensaeth, Knut Haakon
Dahl-Jørgensen, Knut
Margeirsdottir, Hanna Dis
Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function
title Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function
title_full Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function
title_fullStr Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function
title_full_unstemmed Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function
title_short Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function
title_sort advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445493/
https://www.ncbi.nlm.nih.gov/pubmed/28545398
http://dx.doi.org/10.1186/s12872-017-0551-0
work_keys_str_mv AT brunvandleif advancedglycationendproductsinchildrenwithtype1diabetesandearlyreduceddiastolicheartfunction
AT heiermartin advancedglycationendproductsinchildrenwithtype1diabetesandearlyreduceddiastolicheartfunction
AT brunborgcathrine advancedglycationendproductsinchildrenwithtype1diabetesandearlyreduceddiastolicheartfunction
AT hanssenkristianf advancedglycationendproductsinchildrenwithtype1diabetesandearlyreduceddiastolicheartfunction
AT fugelsethdrude advancedglycationendproductsinchildrenwithtype1diabetesandearlyreduceddiastolicheartfunction
AT stensaethknuthaakon advancedglycationendproductsinchildrenwithtype1diabetesandearlyreduceddiastolicheartfunction
AT dahljørgensenknut advancedglycationendproductsinchildrenwithtype1diabetesandearlyreduceddiastolicheartfunction
AT margeirsdottirhannadis advancedglycationendproductsinchildrenwithtype1diabetesandearlyreduceddiastolicheartfunction